NIH Funding Opportunities and Notices for January 20, 2017

 

Please note of the following new Notices from NIH

 

Notices

(NOT-OD-17-037) National Institutes of Health

(NOT-OD-17-038) National Institutes of Health

(NOT-OD-17-039) National Institutes of Health

NIH Implementation of the Interim-RPPR while a Renewal Application is Under Consideration

Notice of the Publication of the Final Rule on the Federal Policy for the Protections of Human Subjects (Common Rule)

Registration Open for the Spring 2017 NIH Regional Seminar on Program Funding & Grants Administration - New Orleans, Louisiana 

 

The following RFAs and PAs may be of interest to CTRs and appropriate COBREs

Requests for Applications

(RFA-HL-18-003)

National Heart, Lung, and Blood Institute

Application Receipt Date(s): June 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

(RFA-NS-17-020)

National Institute of Neurological Disorders and Stroke

Application Receipt Date(s): March 21, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

Sex Hormone Induced Thromboembolism in Pre-Menopausal Women (R61/R33)

 

Research Program Award (R35)

Program Announcements

(PA-17-085) 

Eunice Kennedy Shriver National Institute of Child Health and Human Development 

National Eye Institute

National Institute of Allergy and Infectious Diseases

National Institute of Biomedical Imaging and Bioengineering

National Institute on Deafness and Other Communication Disorders

National Institute of Dental and Craniofacial Research

National Institute of Neurological Disorders and Stroke

Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

(PAR-17-123) 

National Institute of Diabetes and Digestive and Kidney Diseases

Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

(PAR-17-124) 

National Cancer Institute

National Institute of Biomedical Imaging and Bioengineering

Application Receipt/Submission Date(s): May 30, 2017; September 26, 2017; May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

(PAR-17-125) 

National Cancer Institute

National Institute of Biomedical Imaging and Bioengineering

Application Receipt/Submission Date(s): May 30, 2017; September 26, 2017; May 30, 2018; September 26, 2018; May 30, 2019; September 26, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

(PAR-17-126) 

National Institute on Aging

Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 5, 2017 Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

(PAR-17-127) 

National Institute on Aging

Application Receipt/Submission Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 16, 2017. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

(PAR-17-128) 

National Cancer Institute

Application Receipt/Submission Date(s): May 9, 2017; September 12, 2017; January 9, 2018; May 9, 2018; September 12, 2018; January 9, 2019; May 9, 2019; September 12, 2019; January 9, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

(PAR-17-129) 

National Cancer Institute

Application Receipt/Submission Date(s): May 9, 2017; September 12, 2017; January 9, 2018; May 9, 2018; September 12, 2018; January 9, 2019; May 9, 2019; September 12, 2019; January 9, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Zika Virus (ZIKV) Complications (R21)

Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the NIDDK Repository (R01)

Perception and Cognition Research to Inform Cancer Image Interpretation (R21)

Perception and Cognition Research to Inform Cancer Image Interpretation (R01)

Juvenile Protective Factors and Their Effects on Aging (R01)

Juvenile Protective Factors and Their Effects on Aging (R03)

Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3)

 

Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01)